Bevacizumab/Erlotinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab and erlotinib that may be used in the treatment of epidermal growth factor receptor (EGFR)-positive kidney cancer and non-small cell lung cancer (NSCLC).

**Synonyms:** - Avastin-Tarceva - Avastin/Tarceva - Bevacizumab-Erlotinib - Bevacizumab-Erlotinib Regimen - Erlotinib and Bevacizumab - Erlotinib and Bevacizumab-adcd - Erlotinib and Bevacizumab-awwb - Erlotinib and Bevacizumab-aybi - Erlotinib and Bevacizumab-bvzr - Erlotinib and Bevacizumab-equi - Erlotinib and Bevacizumab-maly - Erlotinib and Bevacizumab-onbe - Erlotinib and Bevacizumab-tnjn - Erlotinib-Bevacizumab - Erlotinib/Bevacizumab - Erlotinib/Bevacizumab Regimen - Tarceva/Avastin